Clinical Trials · NCT06603571
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Eli Lilly and Company
- Enrollment
- 350
- Start date
- Sep 2024
- Locations
- 52 sites, United States, Argentina
- Primary endpoint
- Percent Change from Baseline in Body Weight